# Silence Therapeutics plc: Form 6-K, filed May 16, 2024

- Company: [Silence Therapeutics plc](/companies/sln.md) (CIK 1479615)
- Form: 6-K
- Filed: 2024-05-16
- Accepted by EDGAR: May 16, 2024, 18:21 ET
- Period: 2024-03-31
- Accession: 0000950170-24-060977
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1479615/000095017024060977/sln-6-k-q1_24_final.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1479615/000095017024060977/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1479615/000095017024060977/sln-6-k-q1_24_final.htm

Filed May 16, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-060977. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.